All lobbying filings

TODD STRATEGY GROUP

Lobbying for CAREDX, INC. · Molecular diagnostics.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · $60,000.00 income · posted Jul 20, 2026

Official filing document

Bills named in this filing 1

HR 5269
RESULTS Act

Lobbying activity 1

Medicare/Medicaid

Medicare coverage of molecular testing for solid organ allograft rejection. Medicare payment of clinical laboratory tests. Implementation of Sec 216 of the Protecting Access to Medicare Act of 2014 (PL 113-93) and RESULTS Act (H.R.5269). Prior authorization of molecular tests.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.